AstraZeneca’s Camizestrant Falls Short in Key First‑Line Breast Cancer Trial
AstraZeneca reports camizestrant did not beat standard therapy in SERENA-4 first-line trial, limiting its broader use beyond an existing U.S. approval.
United States
Read Full News
Putin Meets US Envoys; Moscow Describes Talks as “Highly Useful”
Kremlin aide calls meetings with US envoys highly useful as Washington seeks to restart stalled Russia–Ukraine negotiations.
U.S. Completes Strikes on IRGC Targets, Escalation Follows Weekend Clashes
U.S. forces said they completed strikes on IRGC targets in Iran, hitting air defences, radar, maritime and communications sites after weekend clashes.
El-Sayed Rebukes Vance After ‘Very, Very Evil’ Remark at Detroit Rally
Abdul El-Sayed responded to Vice President Vance’s ‘very, very evil’ comment, saying ‘What’s evil is corrupting yourself.’
Sanofi alerts patients and clinicians as supplies of two Pompe disease medicines dwindle
Sanofi has notified clinicians and patient groups that supplies of Myozyme and Nexviazyme for Pompe disease are dwindling due to bottlenecks and quality-control issues at its Waterford, Ireland, manufacturing site, which handles batch release for multiple markets.
SummerSlam Night 2 takeaways: Roman Reigns win ends rivalry with Seth Rollins
SummerSlam Night 2 presented new champions, a surprise return and a main event between two equally matched rivals Sunday at U.S. Bank Stadium in Minneapolis. Roman Reigns put the World Heavyweight Championship on the line against Seth Rollins to close SummerSlam in a match full of callbacks to their days in The Shield. Reigns emerged…